Novel double loaded quercetin liposomes: Evidence of superior therapeutic potency against CCL4 induced hepatotoxicity - A comparative study

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue 2, 2012, Pages 104-108

  Shaji, Jessy ^a   Iyer, Sneha ^a  

^a PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

Author keywords

Beta cyclodextrin; Carbon tetrachloride; Hepatoprotective; Liposomes; Quercetin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBON TETRACHLORIDE; CATALASE; DRUG CARRIER; GLUTATHIONE; LIPOSOME; QUERCETIN; SILYMARIN; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL DEATH; CELL INFILTRATION; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DEGRANULATION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; ENZYME BLOOD LEVEL; FEMALE; HISTOLOGY; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER PROTECTION; LIVER STRUCTURE; LIVER TOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84875445377     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ward F M, Daly M J. Hepatic disease. In. Clinical Pharmacy and Therapeutics. Walker R, Edward C, Eds, Churchill Livingston, New York, 1999; 195-212.
2. Stickel F, Schuppan D. Herbal medicine in the treatment for liver diseases. Dig. Liver. Dis. 2007; 39: 293-304.
3. Herrmann K. Flavonols and flavones in food plants: a review. International Journal of Food Science & Technology. 1976; 11: 433-48.
4. Gross M, Pfeiffer M, Martini M, Campbell D, Slavin J, Potter J. The quantitation of metabolites of quercetin flavonols in human urine. Cancer Epidemiol. Biomarkers Prev 1996; 5: 711-20.
5. Middleton Jr. E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev 2000; 42 (4): 673-751.
6. Lakhanpal P, Rai DK. Quercetin: A Versatile Flavonoid. Internet Journal of Medical Update 2007; 2 (2): 22-37.
7. Terao J, Piskula MK. Flavonoids and membrane lipid peroxidation inhibition. Nutrition 1999; 15: 790-1.
8. Murray CW, Booth AN, Deeds F, Jones FT. Absorption and metabolism of rutin and quercetin in the rabbit. J Am Pharm Assoc 1954; 43:361-4.
9. Lesser S, Cermak R, Wolffram S. Bioavailability of Quercetin in Pigs Is Influenced by the Dietary Fat Content. J Nutr 2004; 134(6): 1508-11.
10. McCormack B, Gregoriadis G. Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int. J. Pharm 1994; 112 (3): 249-58.
11. Nagai T, Kurozumi M, Nambu N. Inclusion Compounds of Non-Steroidal Antiinflammatory and Other Slightly Water Soluble Drugs with α-and β-Cyclodextrins in Powdered Form. Chem. Pharm. Bull 1975; 23 (12): 3062-8.
12. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol 1965; 13 (1): 238-52.
13. Rao PGM, Rao SG, Kumar V, Ramnarayan K, Nayak SS, Kamath SK et al. Effects of Hepatogard against carbon tetrachloride induced liver damage in rats. Fitoterapia 1993; 64: 108-13.
14. Sharstry RA, Biradar SM, Mahadevan KM, Habbu PV. Isolation and Characterization of Secondary Metabolite from Amorphophallus paeoniifolius for Hepatoprotective activity. RJPBCS 2010; 1(4): 429-37.
15. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70.
16. Sun M, Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine auto-oxidation. Anal Biochem 1978; 90(1): 81-89.
17. Clairborne A. Catalase activity. In: Greenwald RA, editors. CRS Handbook of Methods in Oxygen Radical Research. Boca Raton: CRS Press; 1991.p.283-4.
18. Malloy HT, Evelyn KA. The determination of Bilirubin with the Photoelectric Colorimeter. J. Biol. Chem 1937; 119: 481-90.
19. Reitman S, Frankel S. A colorimetric method for the determination of serumglutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. path 1957; 28:56-63.
20. Setchell KD, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002; 76(2): 447-53.
21. Movileanu L, Neagoe I, Flonta ML. Interaction of the antioxidant flavonoid quercetin with planar lipid bilayers. Int J Pharm 2000; 205: 135-46.
22. HernandezMunoz R, DiazMunoz M, Lopez V, Lopez-Barrera F, Yanez L, Vidrio S et al. Balance between oxidative damage and proliferative potential in an experimental rat model of CCl4-induced cirrhosis: protective role of adenosine administration. Hepatology 1997; 26:1100-10.
23. Meister A. New aspects of glutathione biochemistry and transport selective alteration of glutathione metabolism. Nutr Rev 1984; 42: 397-410.